SCHEMBL6534832

SCHEMBL6534832

CC(=O)Nc1ccc(CCCCO)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.56
CYP4A11 Q02928 1/20 0.56
SPHK1 Q9NYA1 6/20 0.55
POLB P06746 1/20 0.53
AOC3 Q16853 1/20 0.53
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
TSHR P16473 2/20 0.51
TDP1 Q9NUW8 1/20 0.50
SPHK2 Q9NRA0 1/20 0.50
MEN1 O00255 1/20 0.50
CA12 O43570 1/20 0.50
BRD4 O60885 1/20 0.50
NR1I2 O75469 1/20 0.50
ALDH1A1 P00352 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
MB P02144 1/20 0.50
CYP1A1 P04798 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14645643 0.95 CYP4A11 (0.54) CYP4F2CYP4A11SPHK1POLBAOC3
SCHEMBL11116153 0.93 SMN1; SMN2 (0.59) POLBAOC3HTTSMN1; SMN2L3MBTL1
SCHEMBL1902060 0.89 SMN1; SMN2 (0.59) POLBAOC3HTTSMN1; SMN2L3MBTL1
SCHEMBL6629816 0.87 SMN1; SMN2 (0.57) CYP4F2CYP4A11POLBAOC3HTT
SCHEMBL5546226 0.86 POLB (0.66) SPHK1POLBSMN1; SMN2CA12CA1
SCHEMBL29622963 0.85 AOC3 (0.67) POLBAOC3HTTSMN1; SMN2L3MBTL1
SCHEMBL29622962 0.85 AOC3 (0.67) POLBAOC3HTTSMN1; SMN2L3MBTL1
SCHEMBL25162168 0.84 POLB (0.51) POLBAOC3HTTSMN1; SMN2L3MBTL1
SCHEMBL11297385 0.84 THRA (0.68) SPHK1POLBSPHK2CA12CA1
SCHEMBL3027338 0.84 THRA (0.68) SPHK1POLBSPHK2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1038018-A4 ALDOL CONDENSATIONS BY CATALYTIC ANTIBODIES SCRIPPS RESEARCH INST (US) 2004-10-13 EP disclosed
US-6589766-B1 Use to catalyze ketone-ketone, ketone-aldehyde, aldehyde-ketone, and aldehyde-aldehyde intermolecular aldol reactions, and in some cases to catalyze their subsequent dehydration to yield aldol condensation products THE SCRIPPS RESEARCH INSTITUTE 2003-07-08 US disclosed
US-6326176-B1 ALDOL CONDENSATIONS AND CATALYTIC ANTIBODIES THE SCRIPPS RESEARCH INSTITUTE 2001-12-04 US disclosed
EP-1038018-A1 ALDOL CONDENSATIONS BY CATALYTIC ANTIBODIES The Scripps Research Institute (US) 2000-09-27 EP disclosed
WO-1999031263-A1 ALDOL CONDENSATIONS BY CATALYTIC ANTIBODIES THE SCRIPPS RESEARCH INSTITUTE (US) 1999-06-24 WO disclosed
EP-0131302-B1 IMIDAZOLIUM SALTS, INTERMEDIATES THERETO AND THEIR USE SCHERING AKTIENGESELLSCHAFT (DE) 1992-01-29 EP disclosed
US-4689341-A Antiarrhythmic imidazoles SCHERING A.G. (DE) 1987-08-25 US disclosed
US-4613609-A Antiarrhythmic imidazoliums SCHERING A. G. (DE) 1986-09-23 US disclosed
US-4581370-A Antiarrhythmic imidazoliums SCHERING A.G. (DE) 1986-04-08 US disclosed
EP-0131302-A2 Imidazolium salts, intermediates thereto and their use SCHERING AKTIENGESELLSCHAFT (DE) 1985-01-16 EP disclosed